+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sweden Cold Chain for Pharma & Food Market

  • PDF Icon

    Report

  • 86 Pages
  • September 2025
  • Region: Sweden
  • Ken Research Private Limited
  • ID: 6212395

Sweden Cold Chain for Pharma & Food Market is valued at USD 1.8 billion, driven by perishable goods demand, e-commerce growth, and tech advancements in logistics.

The Sweden Cold Chain for Pharma & Food Market is valued at approximately USD 1.8 billion, based on a five-year historical analysis. This growth is primarily driven by the expanding consumption of perishable items such as food, pharmaceuticals, and biologics, as well as rising health consciousness and consumer preference for fresh and frozen foods. The expansion of e-commerce, particularly in grocery and pharmaceuticals, and the need for efficient logistics solutions have further fueled the market's growth. Technological advancements, including IoT-enabled tracking, automation, and energy-efficient refrigeration, are also enhancing operational efficiency and supply chain reliability.

Key cities such as Stockholm, Gothenburg, and Malmö dominate the market due to their strategic locations, advanced infrastructure, and proximity to major transportation hubs. These cities serve as critical logistics centers, facilitating the efficient distribution of temperature-sensitive goods across Sweden and supporting both domestic and international trade. Southern Sweden, in particular, leads due to its concentration of key industries, population density, and access to major ports.

In 2023, the Swedish government implemented regulations mandating that all pharmaceutical cold chain logistics must adhere to strict temperature control standards. Specifically, the LVFS 2004:7 Regulation on Good Distribution Practice for Medicinal Products for Human Use, issued by the Swedish Medical Products Agency, requires all entities involved in the distribution of pharmaceuticals to maintain temperature integrity throughout the supply chain, ensure real-time temperature monitoring, and comply with documentation and reporting standards. These regulations align with EU GDP guidelines and are enforced to protect product efficacy and patient safety.

Sweden Cold Chain for Pharma & Food Market Segmentation

By Type:

The cold chain market can be segmented into storage, transport, value-added services, temperature-controlled packaging, and monitoring & tracking systems. Each of these segments is essential for the safe and efficient handling of temperature-sensitive products. Storage and transport remain the largest segments, with value-added services and advanced monitoring solutions gaining importance due to regulatory and quality requirements.

The transport segment, particularly refrigerated trucks, dominates due to the increasing demand for efficient and reliable delivery of temperature-sensitive products. The rise of e-commerce and consumer expectations for rapid, safe delivery of perishables have further amplified this need. Advancements in logistics technology, such as real-time tracking and temperature monitoring, have enhanced the efficiency and reliability of transport services.

In end-user segmentation, the food and beverages sector leads, driven by consumer demand for fresh and safe products and reinforced by food safety regulations. The pharmaceutical sector is also significant, with the growing need for biopharmaceuticals and vaccines requiring stringent temperature controls during storage and transport.

Direct distribution is the leading mode of distribution, reflecting the need for immediate and reliable delivery of temperature-sensitive products. E-commerce platforms are expanding rapidly as consumers increasingly shop online for perishables, while third-party logistics providers are gaining traction for their specialized cold chain services.

The vaccine and biologic distribution segment is crucial, especially given the recent surge in demand for temperature-sensitive pharmaceuticals and the expansion of Sweden's pharmaceutical exports. Perishable food delivery remains significant, supported by the growth of online grocery shopping and consumer demand for fresh products.

Refrigerated trucks and containers dominate the packaging type segment due to their essential role in maintaining required temperatures during transport. The demand for insulated containers and active packaging solutions is also increasing, providing additional protection for sensitive products.

Transportation services are the backbone of the cold chain market, accounting for the largest share due to the need for timely and safe delivery of temperature-sensitive goods. Warehousing services are also significant, especially in urban areas where inventory management is critical.

The chilled temperature range segment is the most significant, driven by the need to maintain the quality of perishable food and pharmaceuticals. The frozen segment is also substantial, particularly for products requiring long-term storage and transport, such as frozen foods and certain vaccines.

Sweden Cold Chain for Pharma & Food Market Competitive Landscape

The Sweden Cold Chain for Pharma & Food Market is characterized by a dynamic mix of regional and international players. Leading participants such as DHL Supply Chain, Kuehne + Nagel, DB Schenker, Bring Frigo AB, PostNord TPL AB, Thermo-Transit AB, Freja Transport & Logistics AB, NTEX AB, Spedman Global Logistics AB, LBC Frakt AB, Ahola Transport AB, A.P. Moller - Maersk, Geodis, FedEx Express Sweden, UPS Supply Chain Solutions contribute to innovation, geographic expansion, and service delivery in this space.

Sweden Cold Chain for Pharma & Food Market Industry Analysis

Growth Drivers

Increasing Demand for Temperature-Sensitive Products:

The Swedish market for temperature-sensitive products is projected to reach approximately 1.5 billion SEK in future, driven by the rising consumption of pharmaceuticals and perishable food items. The biopharmaceutical sector alone is expected to contribute around 600 million SEK, reflecting a 10% annual increase in demand. This surge is largely attributed to an aging population and a growing preference for fresh, organic food, necessitating robust cold chain solutions.

Expansion of E-commerce in Food and Pharma:

E-commerce sales in Sweden are anticipated to exceed 200 billion SEK in future, with a significant portion attributed to food and pharmaceutical products. The online grocery segment is expected to grow by 15% annually, reaching 30 billion SEK. This shift towards online shopping is driving the need for efficient cold chain logistics to ensure product integrity during transportation, thereby enhancing market growth.

Technological Advancements in Cold Chain Logistics:

The adoption of advanced technologies in cold chain logistics is projected to enhance operational efficiency, with investments in automation and IoT solutions expected to reach 1 billion SEK by future. These technologies facilitate real-time monitoring and tracking of temperature-sensitive products, reducing spoilage rates by up to 20%. This innovation is crucial for maintaining compliance with stringent safety regulations in the pharmaceutical and food sectors.

Market Challenges

High Operational Costs:

The operational costs associated with cold chain logistics in Sweden are estimated to be around 30% higher than traditional logistics due to the need for specialized equipment and energy consumption. In future, energy costs are projected to rise by 5%, further straining profit margins for cold chain operators. This financial burden can hinder investment in necessary infrastructure and technology upgrades.

Limited Infrastructure in Remote Areas:

Approximately 20% of Sweden's rural areas lack adequate cold chain infrastructure, which poses significant challenges for the distribution of temperature-sensitive products. In future, it is estimated that 15% of the population in these regions will face difficulties accessing essential pharmaceuticals and fresh food. This infrastructure gap can lead to increased delivery times and product spoilage, impacting overall market efficiency.

Sweden Cold Chain for Pharma & Food Market Future Outlook

The future of the cold chain market in Sweden appears promising, driven by technological innovations and increasing consumer demand for temperature-sensitive products. As e-commerce continues to expand, companies are likely to invest in smart cold chain solutions that enhance efficiency and traceability. Additionally, the focus on sustainability will push for eco-friendly refrigeration technologies, aligning with global environmental goals. These trends will shape the market landscape, fostering growth and resilience in the face of challenges.

Market Opportunities

Growth in Biopharmaceuticals:

The biopharmaceutical sector is expected to grow significantly, with an estimated market value of 800 million SEK by future. This growth presents opportunities for cold chain providers to develop specialized logistics solutions tailored to the unique requirements of biopharmaceutical products, enhancing service offerings and market competitiveness.

Increasing Focus on Sustainable Practices:

With sustainability becoming a priority, investments in eco-friendly cold chain technologies are projected to reach 500 million SEK by future. Companies that adopt green practices, such as energy-efficient refrigeration and sustainable packaging, will not only comply with regulations but also attract environmentally conscious consumers, enhancing their market position.

Table of Contents

1. Sweden Cold Chain for Pharma & Food Market Overview
1.1. Definition and Scope
1.2. Market Taxonomy
1.3. Market Growth Rate
1.4. Market Segmentation Overview
2. Sweden Cold Chain for Pharma & Food Market Size (in USD Bn), 2019-2024
2.1. Historical Market Size
2.2. Year-on-Year Growth Analysis
2.3. Key Market Developments and Milestones
3. Sweden Cold Chain for Pharma & Food Market Analysis
3.1. Growth Drivers
3.1.1. Increasing Demand for Temperature-Sensitive Products
3.1.2. Expansion of E-commerce in Food and Pharma
3.1.3. Technological Advancements in Cold Chain Logistics
3.1.4. Stringent Regulatory Requirements for Product Safety
3.2. Restraints
3.2.1. High Operational Costs
3.2.2. Limited Infrastructure in Remote Areas
3.2.3. Fluctuating Energy Prices
3.2.4. Compliance with International Standards
3.3. Opportunities
3.3.1. Growth in Biopharmaceuticals
3.3.2. Increasing Focus on Sustainable Practices
3.3.3. Development of Smart Cold Chain Solutions
3.3.4. Expansion into Emerging Markets
3.4. Trends
3.4.1. Adoption of IoT in Cold Chain Management
3.4.2. Rise of Automated Warehousing Solutions
3.4.3. Integration of Blockchain for Traceability
3.4.4. Shift Towards Eco-Friendly Refrigeration Technologies
3.5. Government Regulation
3.5.1. EU Regulations on Food Safety
3.5.2. National Guidelines for Pharmaceutical Distribution
3.5.3. Environmental Regulations on Refrigerants
3.5.4. Compliance Standards for Cold Chain Logistics
3.6. SWOT Analysis
3.7. Stakeholder Ecosystem
3.8. Competition Ecosystem
4. Sweden Cold Chain for Pharma & Food Market Segmentation, 2024
4.1. By Type (in Value %)
4.1.1. Storage (Cold Warehousing)
4.1.2. Transport (Refrigerated Trucks, Rail, Air, Sea)
4.1.3. Value-Added Services (Blast Freezing, Labeling, Inventory Management)
4.1.4. Temperature-Controlled Packaging
4.1.5. Monitoring & Tracking Systems
4.2. By End-User (in Value %)
4.2.1. Pharmaceuticals (Including Biopharma & Vaccines)
4.2.2. Food and Beverages
4.2.3. Biotechnology
4.2.4. Healthcare Providers
4.2.5. Horticulture (Fresh Fruits & Vegetables)
4.2.6. Dairy Products
4.2.7. Fish, Meat, and Poultry
4.2.8. Others
4.3. By Distribution Mode (in Value %)
4.3.1. Direct Distribution
4.3.2. Third-Party Logistics (3PL)
4.3.3. E-commerce Platforms
4.3.4. Others
4.4. By Application (in Value %)
4.4.1. Vaccine & Biologic Distribution
4.4.2. Perishable Food Delivery
4.4.3. Clinical Trials Logistics
4.4.4. Processed Food Distribution
4.4.5. Others
4.5. By Packaging Type (in Value %)
4.5.1. Insulated Containers
4.5.2. Refrigerated Trucks & Containers
4.5.3. Active and Passive Packaging
4.5.4. Others
4.6. By Temperature Range (in Value %)
4.6.1. Chilled (2°C to 8°C)
4.6.2. Frozen (Below -18°C)
4.6.3. Ambient (15°C to 25°C)
4.6.4. Others
5. Sweden Cold Chain for Pharma & Food Market Cross Comparison
5.1. Detailed Profiles of Major Companies
5.1.1. DHL Supply Chain
5.1.2. Kuehne + Nagel
5.1.3. DB Schenker
5.1.4. Bring Frigo AB
5.1.5. PostNord TPL AB
5.2. Cross Comparison Parameters
5.2.1. Revenue (SEK, latest fiscal year)
5.2.2. Market Penetration Rate (Sweden, % share of cold chain market)
5.2.3. Number of Cold Storage Facilities (in Sweden)
5.2.4. Fleet Size (Refrigerated Vehicles in Sweden)
5.2.5. Technology Adoption Level (e.g., IoT, real-time monitoring, automation)
6. Sweden Cold Chain for Pharma & Food Market Regulatory Framework
6.1. Compliance Requirements and Audits
6.2. Certification Processes
7. Sweden Cold Chain for Pharma & Food Market Future Size (in USD Bn), 2025-2030
7.1. Future Market Size Projections
7.2. Key Factors Driving Future Market Growth
8. Sweden Cold Chain for Pharma & Food Market Future Segmentation, 2030
8.1. By Type (in Value %)
8.2. By End-User (in Value %)
8.3. By Distribution Mode (in Value %)
8.4. By Application (in Value %)
8.5. By Packaging Type (in Value %)
8.6. By Temperature Range (in Value %)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • DHL Supply Chain
  • Kuehne + Nagel
  • DB Schenker
  • Bring Frigo AB
  • PostNord TPL AB
  • Thermo-Transit AB
  • Freja Transport & Logistics AB
  • NTEX AB
  • Spedman Global Logistics AB
  • LBC Frakt AB
  • Ahola Transport AB
  • A.P. Moller - Maersk
  • Geodis
  • FedEx Express Sweden
  • UPS Supply Chain Solutions